"Unobtrusive Sensing of Medication Intake (USE-MI)"

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2025

Conditions
Medication Adherence
Interventions
BEHAVIORAL

USE-MI System

"Pilot Phase: 10 subjects will continue with their ART or PrEP medication and begin using the USE-MI system. Subjects will wear a smartwatch every day to monitor their pill taking activity for 1 month and receive weekly phone calls to obtain feedback on the system. During the first call, subjects will respond to 2 questionnaires about how they are taking their daily ART or PrEP pill(s).~Second Phase: Up to 50 subjects will continue with their ART or PrEP medication and begin using the USE-MI system. Subjects will wear a smartwatch every day to monitor their pill taking activity for up to 6 months. During their first month, subjects will receive weekly phone calls to obtain feedback on the system. During the first call, subjects will respond to 2 questionnaires about how they are taking their daily ART or PrEP pill(s). Subjects will then have monthly follow-up visits to complete a brief questionnaire about how they are taking their daily ART or PrEP pill(s)."

Trial Locations (1)

98122

RECRUITING

Swedish Medical Center, Seattle

All Listed Sponsors
collaborator

University of Massachusetts, Amherst

OTHER

collaborator

University of Washington

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Swedish Medical Center

OTHER